company background image
500672 logo

Novartis India BSE:500672 Stock Report

Last Price

₹1.09k

Market Cap

₹26.9b

7D

0.7%

1Y

34.6%

Updated

23 Jun, 2024

Data

Company Financials

Novartis India Limited

BSE:500672 Stock Report

Market Cap: ₹26.9b

500672 Stock Overview

Operates as a healthcare company in India.

500672 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends6/6

Rewards

Risk Analysis

No risks detected for 500672 from our risk checks.

Novartis India Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Novartis India
Historical stock prices
Current Share Price₹1,088.05
52 Week High₹1,224.00
52 Week Low₹599.95
Beta0.36
11 Month Change-1.96%
3 Month Change5.35%
1 Year Change34.63%
33 Year Change23.01%
5 Year Change63.68%
Change since IPO175.46%

Recent News & Updates

Recent updates

Shareholder Returns

500672IN PharmaceuticalsIN Market
7D0.7%-1.7%-0.1%
1Y34.6%50.6%46.3%

Return vs Industry: 500672 underperformed the Indian Pharmaceuticals industry which returned 50.6% over the past year.

Return vs Market: 500672 underperformed the Indian Market which returned 46.3% over the past year.

Price Volatility

Is 500672's price volatile compared to industry and market?
500672 volatility
500672 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 500672 has not had significant price volatility in the past 3 months.

Volatility Over Time: 500672's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194767Vas Narasimhanwww.novartis.in

Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India.

Novartis India Limited Fundamentals Summary

How do Novartis India's earnings and revenue compare to its market cap?
500672 fundamental statistics
Market cap₹26.86b
Earnings (TTM)₹851.90m
Revenue (TTM)₹3.35b

31.5x

P/E Ratio

8.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500672 income statement (TTM)
Revenue₹3.35b
Cost of Revenue₹2.00b
Gross Profit₹1.35b
Other Expenses₹500.40m
Earnings₹851.90m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)34.50
Gross Margin40.36%
Net Profit Margin25.42%
Debt/Equity Ratio0.003%

How did 500672 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

72%

Payout Ratio

Does 500672 pay a reliable dividends?

See 500672 dividend history and benchmarks
When do you need to buy 500672 by to receive an upcoming dividend?
Novartis India dividend dates
Ex Dividend DateJul 23 2024
Dividend Pay DateAug 30 2024
Days until Ex dividend29 days
Days until Dividend pay date67 days

Does 500672 pay a reliable dividends?

See 500672 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.